Simple Summary US-MRI fusion biopsy is established as a technique of reference for the
detection of clinically significative prostate cancer compared to the ultrasound “template” …

Targeted biopsy using multiparametric magnetic resonance imaging increases the detection
rate of clinically significant prostate cancer (csCaP). In this meta-analysis, we compare the …

Background Magnetic resonance imaging (MRI) and ultrasound (US) fusion prostate-
biopsies can be performed in a transrectal (TR-fusion) or transperineal (TP-fusion) …

Objective To perform a systematic review and meta-analysis comparing overall prostate
cancer detection rate and clinically-significant prostate cancer detection rate between MRI …

Background Prostate biopsy supported by transperineal image fusion has recently been
developed as a new method to the improve accuracy of prostate cancer detection. Objective …

Abstract Transrectal ultrasound (TRUS)-guided (12–14 core) systematic biopsy of the
prostate is the recommended standard for patients with suspicion of prostate cancer (PCa) …

Context The current standard for diagnosing prostate cancer in men at risk relies on a
transrectal ultrasound–guided biopsy test that is blind to the location of the cancer. To …

Objective. In this study, we compared prostate cancer detection rates between MRI‐TRUS
fusion targeted and systematic biopsies using a robot‐guided, software based transperineal …

Background The combination of MRI-guided targeted biopsy (MRGB) with systematic biopsy
(SB) provides the highest accuracy in detecting prostate cancer. There is a controversy over …

Context Magnetic resonance imaging (MRI)-targeted biopsies have changed the dogma in
prostate cancer diagnosis. Biopsies can be performed either transrectally (MRI-guided and …